129 related articles for article (PubMed ID: 36361271)
21. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants.
Chaki SP; Kahl-McDonagh MM; Neuman BW; Zuelke KA
Microbiol Spectr; 2022 Jun; 10(3):e0066522. PubMed ID: 35638906
[TBL] [Abstract][Full Text] [Related]
22. First cases of SARS-CoV-2 infection in dogs and cats in Thailand.
Jairak W; Charoenkul K; Chamsai E; Udom K; Chaiyawong S; Bunpapong N; Boonyapisitsopa S; Tantilertcharoen R; Techakriengkrai N; Surachetpong S; Tangwangvivat R; Suwannakarn K; Amonsin A
Transbound Emerg Dis; 2022 Jul; 69(4):e979-e991. PubMed ID: 34739748
[TBL] [Abstract][Full Text] [Related]
23. RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge.
Shi J; Zheng J; Zhang X; Tai W; Odle AE; Perlman S; Du L
Transl Res; 2022 Oct; 248():11-21. PubMed ID: 35489692
[TBL] [Abstract][Full Text] [Related]
24. Middle East respiratory syndrome coronavirus infection in non-camelid domestic mammals.
Kandeil A; Gomaa M; Shehata M; El-Taweel A; Kayed AE; Abiadh A; Jrijer J; Moatasim Y; Kutkat O; Bagato O; Mahmoud S; Mostafa A; El-Shesheny R; Perera RA; Ko RL; Hassan N; Elsokary B; Allal L; Saad A; Sobhy H; McKenzie PP; Webby RJ; Peiris M; Ali MA; Kayali G
Emerg Microbes Infect; 2019; 8(1):103-108. PubMed ID: 30866764
[TBL] [Abstract][Full Text] [Related]
25. Detection of SARS-CoV-2 in a dog with hemorrhagic diarrhea.
Padilla-Blanco M; Vega S; Enjuanes L; Morey A; Lorenzo T; Marín C; Ivorra C; Maiques E; Rubio V; Rubio-Guerri C
BMC Vet Res; 2022 Oct; 18(1):370. PubMed ID: 36224622
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 delta variant infection in domestic dogs and cats, Thailand.
Jairak W; Chamsai E; Udom K; Charoenkul K; Chaiyawong S; Techakriengkrai N; Tangwangvivat R; Suwannakarn K; Amonsin A
Sci Rep; 2022 May; 12(1):8403. PubMed ID: 35589808
[TBL] [Abstract][Full Text] [Related]
27. Molecular epidemiology of SARS-CoV-2 isolated from COVID-19 family clusters.
Gunadi ; Wibawa H; Hakim MS; Marcellus ; Trisnawati I; Khair RE; Triasih R; Irene ; Afiahayati ; Iskandar K; Siswanto ; Anggorowati N; Daniwijaya EW; Supriyati E; Nugrahaningsih DAA; Budiono E; Retnowulan H; Puspadewi Y; Puspitawati I; Sianipar O; Afandy D; Simanjaya S; Widitjiarso W; Puspitarani DA; Fahri F; Riawan U; Fauzi AR; Kalim AS; Ananda NR; Setyati A; Setyowireni D; Laksanawati IS; Arguni E; Nuryastuti T; Wibawa T;
BMC Med Genomics; 2021 Jun; 14(1):144. PubMed ID: 34074255
[TBL] [Abstract][Full Text] [Related]
28. COVID-19 Delta variation; more contagious or more pernicious?
Yazdanpanah F; Yazdanpanah S; Rezaei N
Acta Biomed; 2022 Jan; 92(6):e2021454. PubMed ID: 35075065
[TBL] [Abstract][Full Text] [Related]
29. First evidence of human-to-dog transmission of SARS-CoV-2 B.1.160 variant in France.
Medkour H; Catheland S; Boucraut-Baralon C; Laidoudi Y; Sereme Y; Pingret JL; Million M; Houhamdi L; Levasseur A; Cabassu J; Davoust B
Transbound Emerg Dis; 2022 Jul; 69(4):e823-e830. PubMed ID: 34706153
[TBL] [Abstract][Full Text] [Related]
30. Human-to-dog transmission of SARS-CoV-2, Colombia.
Rivero R; Garay E; Botero Y; Serrano-Coll H; Gastelbondo B; Muñoz M; Ballesteros N; Castañeda S; Patiño LH; Ramirez JD; Calderon A; Guzmán C; Martinez-Bravo C; Aleman A; Arrieta G; Mattar S
Sci Rep; 2022 May; 12(1):7880. PubMed ID: 35551247
[TBL] [Abstract][Full Text] [Related]
31. Missense mutations in spike protein of SARS-CoV-2 delta variant contribute to the alteration in viral structure and interaction with hACE2 receptor.
Mahmood TB; Hossan MI; Mahmud S; Shimu MSS; Alam MJ; Bhuyan MMR; Emran TB
Immun Inflamm Dis; 2022 Sep; 10(9):e683. PubMed ID: 36039645
[TBL] [Abstract][Full Text] [Related]
32. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
33. Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variant.
Rosato AE; Msiha E; Weng B; Mesisca M; Gnass R; Gnass S; Bol C; Tabuenca A; Rosato RR
Pathology; 2022 Apr; 54(3):351-356. PubMed ID: 35221043
[TBL] [Abstract][Full Text] [Related]
34. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.
Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S
Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487
[TBL] [Abstract][Full Text] [Related]
35. Genomic Characterization of an Emerging SARS-CoV-2 Variant During the Early Second Wave of the SARS-CoV-2 Pandemic in Maharashtra, India.
Karyakarte RP; Das R; Joshi S; Jayaram A; Yanamandra S; Shende S; Taji N; Rane S; Bawale R; Chaudhari GP; Karekar B; Sakalkar SR; Tiwari RG; Jadhav MG
Cureus; 2023 Nov; 15(11):e48604. PubMed ID: 38090396
[TBL] [Abstract][Full Text] [Related]
36. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.
Zhang HL; Li YM; Sun J; Zhang YY; Wang TY; Sun MX; Wang MH; Yang YL; Hu XL; Tang YD; Zhao J; Cai X
J Biol Chem; 2021; 296():100435. PubMed ID: 33610551
[TBL] [Abstract][Full Text] [Related]
37. Genome Sequencing Reveals a Mixed Picture of SARS-CoV-2 Variant of Concern Circulation in Eastern Uttar Pradesh, India.
Deval H; Nyayanit DA; Mishra SK; Yadav PD; Zaman K; Shankar P; Misra BR; Behera SP; Kumar N; Kumar A; Bhardwaj P; Dwivedi GR; Singh R; Shete AM; Pandit P; Pandey AK; Yadav GK; Gupta S; Kumar M; Kavathekar A; Singh RS; Prajapati S; Kant R
Front Med (Lausanne); 2021; 8():781287. PubMed ID: 35071267
[TBL] [Abstract][Full Text] [Related]
38. Detection and genome characterisation of SARS-CoV-2 P.6 lineage in dogs and cats living with Uruguayan COVID-19 patients.
Panzera Y; Mirazo S; Baz M; Techera C; Grecco S; Cancela F; Fuques E; Condon E; Calleros L; Camilo N; Fregossi A; Vaz I; Pessina P; Deshpande N; Pérez R; Benech A
Mem Inst Oswaldo Cruz; 2023; 117():e220177. PubMed ID: 36651456
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 variants of concern and spike protein mutational dynamics in a Swedish cohort during 2021, studied by Nanopore sequencing.
Mannsverk S; Bergholm J; Palanisamy N; Ellström P; Kaden R; Lindh J; Lennerstrand J
Virol J; 2022 Oct; 19(1):164. PubMed ID: 36258215
[TBL] [Abstract][Full Text] [Related]
40. Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7.
Peters MH; Bastidas O; Kokron DS; Henze CE
Microbiol Spectr; 2021 Sep; 9(1):e0003021. PubMed ID: 34346753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
